Litigation Settlement, Amount Awarded to Other Party, Percentage of Total Settlement to Be Used to Remediate Damages

No definition available.

Name:	mck_LitigationSettlementAmountAwardedToOtherPartyPercentageOfTotalSettlementToBeUsedToRemediateDamages
Namespace Prefix:	mck_
Data Type:	xbrli:pureItemType
Balance Type:	na
Period Type:	instant

- Definition

Litigation Settlement, Award Amount To Be Used by State and Local Government

+ References

No definition available.

+ Details

Name:	mck_LitigationSettlementAwardAmountToBeUsedByStateAndLocalGovernment
Namespace Prefix:	mck_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Claims Settled, Number Of Jurisdictions Not Participating In Settlement

+ References

No definition available.

+ Details

Name:	mck_LossContingencyClaimsSettledNumberOfJurisdictionsNotParticipatingInSettlement
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number Of Cases Dismissed

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberOfCasesDismissed
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of Other Defendants

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberOfOtherDefendants
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of States Filed On Behalf Of

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberOfStatesFiledOnBehalfOf
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Loss Contingency, Number of States

+ References

No definition available.

+ Details

Name:	mck_LossContingencyNumberofStates
Namespace Prefix:	mck_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Opioid Stewardship Act, New York, Annual Surcharge

+ References

No definition available.

+ Details

Name:	mck_OpioidStewardshipActNewYorkAnnualSurcharge
Namespace Prefix:	mck_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

+ Details

Name:	us-gaap_GainLossRelatedToLitigationSettlement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 720
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483359/720-20-50-1

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 27
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482395/460-10-55-27

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-4

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482425/460-10-50-3

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483076/450-20-50-1

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of cash outflow reducing loss contingency liability.

+ References

+ Details

Name:	us-gaap_LossContingencyAccrualPayments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of plaintiffs that have filed claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of pending claims pertaining to a loss contingency.

+ References

+ Details

Name:	us-gaap_LossContingencyPendingClaimsNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of cash paid for the settlement of litigation or for other legal issues during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Cash received for the settlement of litigation during the current period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 230
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_ProceedsFromLegalSettlements
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=mck_USPharmaceuticalSegmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_US
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_StatementGeographicalAxis=country_CA
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_IndividualClaimantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LossContingenciesByNatureOfContingencyAxis=mck_NewYorkOpioidTaxSurchargeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mck_NationalPrescriptionOpiateLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_StateOfAlabamaAndSubdivisionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_NativeAmericanTribesOtherThanCherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_SettlingGovernmentalEntitiesAndCherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=mck_ThreeLargestUSPharmaceuticalDistributorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=mck_ThreeNationalPharmaceuticalDistributorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_StateOfWestVirginiaAndSubdivisionsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mck_CherokeeNationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mck_UnitedStatesExRelHartVMcKessonCorporationEtAl15Cv00903RAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitments and Contingent Liabilities - Narrative (Details) $ in Millions	1 Months Ended			3 Months Ended		12 Months Ended
	Jul. 31, 2024 USD ($)	May 30, 2024 USD ($)	Dec. 31, 2021 USD ($)	Jun. 30, 2024 USD ($) case distributor subdivision state	Jun. 30, 2023 USD ($)	Mar. 31, 2024 USD ($) plaintiff	Nov. 30, 2022 USD ($)	Jul. 31, 2020 state	Mar. 31, 2018 USD ($)	Mar. 31, 2017 USD ($)
Loss Contingencies [Line Items]
Claims and litigation charges				$ 112	$ 0
Opioid stewardship act, New York, annual surcharge							$ 42		$ 100	$ 100
Proceeds from legal settlements		$ 90		90	$ 118
National Prescription Opioid Litigation
Loss Contingencies [Line Items]
Claims and litigation charges				114		$ 149
National Prescription Opioid Litigation \| U.S. Pharmaceutical
Loss Contingencies [Line Items]
Claims and litigation charges				57		(74)
National Prescription Opioid Litigation \| Corporate Segment
Loss Contingencies [Line Items]
Claims and litigation charges				$ 57		$ (75)
National Prescription Opioid Litigation \| United States
Loss Contingencies [Line Items]
Complaints filed against the entity \| case				400
National Prescription Opioid Litigation \| Canada
Loss Contingencies [Line Items]
Complaints filed against the entity \| case				4
National Prescription Opioid Litigation \| An individual \| United States
Loss Contingencies [Line Items]
Complaints filed against the entity \| case				1
National Prescription Opioid Litigation \| An individual \| Canada
Loss Contingencies [Line Items]
Complaints filed against the entity \| case				1
New York Opioid Tax Surcharge \| U.S. Pharmaceutical
Loss Contingencies [Line Items]
Loss contingency accrual, payments			$ 26
National Prescription Opioid Litigation
Loss Contingencies [Line Items]
Number of other national distributors named in suit \| distributor				2
Number of states in which court cases are pending \| state				48
Loss contingency, number of cases dismissed \| case				2,300
Portion of settlement award to be used by state and local government for remediation (percent)				85.00%
Loss contingency, claims settled, number of jurisdictions not participating in settlement \| subdivision				1
Number of plaintiffs \| plaintiff						1
National Prescription Opioid Litigation \| State of Alabama and Subdivisions
Loss Contingencies [Line Items]
Settlement payment				$ 61
Award payable under proposed framework				$ 113
National Prescription Opioid Litigation \| Native American Tribes Other Than Cherokee Nation
Loss Contingencies [Line Items]
Litigation settlement, amount awarded to other party, percentage of total settlement to be used to remediate damages				0.85
National Prescription Opioid Litigation \| Settling Governmental Entities and Cherokee Nation \| Settled Litigation
Loss Contingencies [Line Items]
Settlement payment				$ 0
National Prescription Opioid Litigation \| Settling Governmental Entities and Cherokee Nation \| Settled Litigation \| Subsequent Event
Loss Contingencies [Line Items]
Settlement payment	$ 500
National Prescription Opioid Litigation \| Three Largest U.S. Pharmaceutical Distributors
Loss Contingencies [Line Items]
Settlement payment				1,500
Award payable under proposed framework				6,300
National Prescription Opioid Litigation \| Three National Pharmaceutical Distributors \| State of West Virginia and Subdivisions
Loss Contingencies [Line Items]
Settlement payment				53
Award payable under proposed framework				99
National Prescription Opioid Litigation \| Three National Pharmaceutical Distributors \| Cherokee Nation
Loss Contingencies [Line Items]
Settlement payment				84
National Prescription Opioid Litigation \| Three National Pharmaceutical Distributors \| Native American Tribes Other Than Cherokee Nation
Loss Contingencies [Line Items]
Award payable under proposed framework				$ 112
United States ex rel. Hart v. McKesson Corporation, et al., 15-cv-00903-RA
Loss Contingencies [Line Items]
Number of states filed on behalf of \| state								27